A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.

REDUCTION OF HEALTH COSTS

Swiss government chooses the wrong medicine with reference price system for drugs

Since autumn 2018 the first package of costcutting measures in Switzerlands health care system is being reviewed One of the measures is the socalled reference price system for pharmaceuticals whose patents have expired Under the leadership of the industry association Intergenerika an alliance of doc..

MEDICAL MARKETING SUPERHEROES

Imagine you could genetically engineer your medical marketing team. You can

One of the big differences between the life science industry and other sectors is the way that the marketing process happens not only in the marketing department but also in sales medical affairs market access and many other departments This distributed competency means that excellent marketing flow..

BLOCKCHAIN TECHNOLOGY

Use Cases in the Pharmaceutical Industry

This paper examines the Blockchain technology applied to the pharmaceutical sector The article is threefold and provides an overview on 1 the Blockchain technology 2 the pharmaceutical industry and its unique complexities and 3 the potential of Blockchain technology to reduce some of those complexit..

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Pharmaceutical business performance is widely perceived to be about robust sales successful launches financial results profit margins and the like However a very crucial measure of success relates to how the industry conducts its business and achieves its mission Ethics and building patients trust a..

WAYS TO CREATE MORE AND MORE CONSISTENT PERFORMERS

For all pharma businesses it is a challenge to enable their field forceSales and Marketingto be consistent performers The success or failure in this direction will accordingly decide the fate of the organisations Even if an organisation has highly innovative molecules in its product basket it is of ..

AN ASIA PACIFIC CRO MARKET ANALYSIS

STEPPING INTO THE FUTURES

The pharmaceutical industry is undergoing several changes that are affecting its growth on a global scale Despite the fact that the AsiaPac market has faced ongoing challenges associated with regulatory ambiguity longdrawn approval timelines and evolving policies an increased global focus on multire..

Why Quality Standards of Drugs has to be the Primary Focus Area for Pharmaceutical Industry

Time and again Indian pharmaceutical industry has faced concerns due to its manufacturing standards and quality which have led to penalties and drops in export figures For the industry to realise its potential to capture world markets the primary focus has to be towards improving quality standards t..

REGULATORY REFORM

How China is investing in its pharmaceutical market

The nuances of clinical and regulatory product development in China and its similarities and contrasting aspects in comparison to the rest of the world are discussed in this article The specifics within risk management and the global regulatory authorities that contribute to this complex landscape w..

Advancing Production Capabilities to Boost China’s Pharmaceutical Market

The path forward is paved with Industry 4.0 and brand security solutions alongside regulatory change and new infrastructure

According to 2017s report by the US Chamber of Commerce on the Made in China 2025 industrial plan an innovation gap leaves the country dependent on foreign companies for patented pharmaceutical drugs As China aims to close that gap companies must advance packaging operations to scale production with..

Integrated Drug Development Strategy

The nexus to value-based pricing

With only 12 per cent of drug candidates entering clinical trials resulting in an approved drug and 20 per cent recouping their investment there is an unquestionable need to change the way pharma develops drugs This paper will show how a modern stateoftheart integrated drug development strategy uses..